Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0168 USD | +17,96% | +9,09% | -73,75% |
Omzet 2022 | 16,84 15,75 | Omzet 2023 | 18,22 17,04 | Marktkapitalisatie | 1,28 mln. 1,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -76 mln. -71,08 mln. | Nettowinst (verlies) 2023 | 53 mln. 49,57 mln. | EV/omzet 2022 | 4.528.434 x |
Nettoschuld 2022 | 68,36 mln. 63,93 mln. | Nettoschuld 2023 | 43,37 mln. 40,57 mln. | EV/omzet 2023 | 2.451.077 x |
K/w-verhouding 2022 |
-0,05
x | K/w-verhouding 2023 |
1,2
x | Werknemers | 38 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Evofem Biosciences, Inc.
1 dag | +17,96% | ||
1 week | +9,09% | ||
Lopende maand | -30,29% | ||
1 maand | -35,38% | ||
3 maanden | -51,86% | ||
6 maanden | -78,97% | ||
Lopend jaar | -73,75% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 01-03-18 |
Amy Raskopf
IRC | Investor Relations Contact | - | 01-02-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 01-01-18 |
Colin Rutherford
BRD | Director/Board Member | 65 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,0168 | +17,96% | 555 899 |
25-04-24 | 0,0142 | -4,70% | 178 028 |
24-04-24 | 0,0149 | +16,04% | 740 620 |
23-04-24 | 0,0128 | -19,25% | 1 921 977 |
22-04-24 | 0,0159 | +3,25% | 157 974 |
uitgestelde koers OTC Markets, 26 april 2024 om 21:58 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-73,75% | 929K | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |